Looking for Income

What neurotoxicities are associated with T-cell therapies? How are these toxicities managed? What is the risk of delayed toxicity?
Why is chromosome 14 a site of high-risk myeloma genetics?
What is the difference between light chain myeloma and amyloidosis?
Why is it important for a myeloma patient to be aware of the symptoms of amyloidosis?
Why does the list of chromosomal abnormalities that are consider high risk change or evolve over time?
What are the International Myeloma Working Group's consensus imaging guidelines for myeloma?